- Projected Return
- Projected Timeline
SGD $333,220.00Fundraising Goal
12Days to go
PT GUNTUR DUA PULUH (G20)
Founded in 2018, PT Guntur Dua Puluh (G20) provides labor and event management services under a subsidiary of the Kimia Farma Pension Fund.
G20’s strong management team has more than 15 years of experience in managing outsource agencies and events. G20 branches are spread across the major cities of Indonesia at the client’s request.
Established by the Dutch Indies Government in 1817 as NV Chemicalien Handle Rathkamp & Co, Kimia Farma is the first pharmaceutical company in Indonesia.
The company later became PNF Bhinneka Kimia Farma following the merger of several pharmaceutical companies in 1958 by the government of the Republic of Indonesia based on the policy of nationalization of ex Dutch companies during the beginning of the independence period.
On 16 August 1971, PNF changed its status as a legal entity into a Limited Liability Company. This also changed the company’s name to PT Kimia Farma (Persero).
On 4 July 2001, PT Kimia Farma (Persero) went public on the Jakarta Stock Exchange and Surabaya Stock Exchange (now known as the Indonesia Stock Exchange).
Today, Kimia Farma is a leading integrated health service in Indonesia. It is known for its heavy involvement in developing the country, particularly in aiding the health of many Indonesian communities.
Investments made in other currencies will be converted to Indonesia Rupiah (IDR) for project use. Investors may incur fx (currency) losses if there is a depreciation in the IDR to their own currency.
There is no fx guarantee or currency hedging done for investors. A higher projected ROI has been agreed upon with the project company to account for this.
EMPLOYEE TURNOVER RISK
There is a risk that trained employees either cancel or are unable to work at the site.
G20 has a lot of worker substitutions to replace these workers.
Investors will appoint PT SMB to enter into a Musharakah partnership with G20. The purpose of this Musharakah partnership is to allow G20 to receive funding necessary for the completion of the working order from Kimia Farma.
G20 will issue the invoice to Kimia Farma after the work order is completed. Kimia Farma will make payment to G20’s bank account, which Ethis will have access.
Upon receiving the payment, G20 will pay the investors their capital and profit (if any) and the Musharakah partnership will be dissolved.
This investment opportunity is based on a first come first serve basis. Your investment is secured only after your transfer-proof has been received. A pledge is merely an interest to invest and does not guarantee you a slot in this investment.
This campaign facts and the content herein do not constitute as any financial advice, or solicitation for the purposes of making financial investments in Indonesia or other territories. Ethis.co is a platform specialising in the match-making of opportunities to those who register themselves as members on the Ethis platform. With regards to these opportunities, the need and onus to do due diligence lies squarely with our members as we do not profess to advise on the same. All dealings and transactions are directly with the businesses, project owners or authorised agents we refer to our members.
In the event of non-performance or default by the project owner, Ethis will initiate a recovery process and handle the initial administrative steps. Should there be a need to pursue further action, investors will need to agree to and bear any additional costs incurred.